Skip to main contentSkip to navigation
Sirius Investors
Actavia Life Sciences, Inc.

Actavia Life Sciences, Inc.

RASP
OTCHealthcare

Market Capitalization & Enterprise Value

Research-grade valuation history for RASP. Track market capitalization versus enterprise value to see the impact of net debt and share changes. Use the interactive chart to explore different horizons; the table updates accordingly to support auditability and export.

Market Cap & Enterprise Value

Comparison of market capitalization and enterprise value over time

Market Cap

Market Capitalization = Stock Price × Number of Shares Outstanding. Represents the total value of a company's equity.
11.56M
+282.97% over period
CAGR: +13.99%
Compound Annual Growth Rate - The mean annual growth rate over time, accounting for compounding effects.

Enterprise Value

Enterprise Value = Market Cap + Total Debt - Cash and Cash Equivalents. Represents the total value of a company including its debt.
11.70M
+293.52% over period
CAGR: +14.29%
Compound Annual Growth Rate - The mean annual growth rate over time, accounting for compounding effects.

Market Cap History

Investor Valuation Insights

As of Mar 31, 2024

EV/EBITDA

Distorted

-89.13x

Negative EV/EBITDA usually means negative EBITDA; compare with revenue and cash flow metrics.

EV vs Market Cap Spread

135.99K

EV is +1.2% vs equity value

Capital Structure Signal

Net Debt Profile

EV premium trend: +2.7 pp vs earliest data

Additional Multiples

EV/Sales: 0.00x

Net Debt/EBITDA: -4.27x

Share count change in dataset: +11683.76%

Interpretation guide: EV/EBITDA compares total firm value (debt + equity - cash) to operating earnings. Lower is usually cheaper, but always benchmark against peers, growth rate, margins, and cyclicality.

Market Cap & Enterprise Value Data

Free users can view the latest 3 records. Upgrade to see full history.

Upgrade
DateMarket CapEnterprise ValueStock PriceShares
Sep 30, 202311.56M11.70M$0.02578.02M
Sep 30, 2022837.63K1.02M$0.0168.66M
Sep 30, 20214.13M4.72M$0.0668.91M
Sep 30, 2020
Sep 30, 2019
Sep 30, 2018
Mar 31, 2017
Jun 30, 2016
Jun 30, 2015
Jun 30, 2014
Jun 30, 2013

Enterprise Value Analysis

Price Change (Sep 2022 to Sep 2023)

The stock price has increased from Sep 2022 to Sep 2023.
+63.93%

Recent Volatility

The stock price has been relatively volatile over the last 5 periods, indicating a higher risk profile.
0.54

Risk-Adjusted Return

The stock's returns do not compensate for its risk level, suggesting a poor risk-reward profile.
-0.40

Market Cap Change (Sep 2022 to Sep 2023)

The company's market capitalization has increased from Sep 2022 to Sep 2023.
13.8x increase

Enterprise Value Change (Sep 2022 to Sep 2023)

The company's enterprise value has increased from Sep 2022 to Sep 2023, suggesting growth in the company's total economic value.
11.5x increase

Market Cap vs. Enterprise Value

A lower enterprise value growth rate compared to market cap growth could suggest that the company is reducing debt or increasing cash reserves.
Market Cap Growth > EV Growth

Market Cap CAGR

The Compound Annual Growth Rate (CAGR) of market capitalization represents the mean annual growth rate over the entire available history (11 periods), accounting for compounding effects.
13.99%

Enterprise Value CAGR

The Compound Annual Growth Rate (CAGR) of enterprise value represents the mean annual growth rate over the entire available history (11 periods), accounting for compounding effects.
14.29%